| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |